Hively Brad sold 298,853 shares of Starling Oncology, Inc. at $6.51 for −$1.95M on Aug 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Aug 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,946,310.05Shares × reported price
Shares traded
298,853Common Stock
Price per share
$6.51Reported price. Read footnotes for ranges.
% of reported position traded
42.04%This security and ownership context
Holdings after
411,976Direct
Trade date
Aug 21, 2026Sell
Filed
Aug 24, 2026, 5:11 PM ET3-day reporting delay
Accession
0001079973-26-001175Code S · Transaction 84174
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 710,829 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

STLN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
STLN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −14%1w ago +5.2%1d ago +6.7%
Returns since7d −3.6%30d +11%90d180d1y

Footnotes in full

F1: Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.37 to $6.75 per share. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided.